2015
Value of Antimullerian hormone and antral follicle count in predicting fertility preservation cycle outcomes
Emirdar V, Turan V, Moy F, Bedoschi G, Oktay K. Value of Antimullerian hormone and antral follicle count in predicting fertility preservation cycle outcomes. Fertility And Sterility 2015, 104: e264. DOI: 10.1016/j.fertnstert.2015.07.829.Peer-Reviewed Original Research
2011
The role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation
Arslan E, Karsy M, Moy F, Oktay K. The role of combined anti-mullerian hormone and antral follicle count assessment in predicting cycle outcomes in cancer patients undergoing controlled ovarian stimulation for fertility preservation. Fertility And Sterility 2011, 96: s201. DOI: 10.1016/j.fertnstert.2011.07.778.Peer-Reviewed Original Research
2010
Does higher starting dose of FSH stimulation improve fertility preservation cycle outcomes in women with breast cancer?
Oktay K, Lee S. Does higher starting dose of FSH stimulation improve fertility preservation cycle outcomes in women with breast cancer? Fertility And Sterility 2010, 94: s160. DOI: 10.1016/j.fertnstert.2010.07.637.Peer-Reviewed Original Research